1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale

1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 

12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...

12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies

12/30/2024CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...

12/30/2024Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene

12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC

12/30/20242025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...

12/30/2024NMPA Announces Package Insert Revision of Potassium Bismuth Citrate Gr...

12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...

12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...

12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...

12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing

12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics

12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...

12/27/2024Recent Executive Moves

12/27/2024AusperBio Secures $73M in Series B Financing to Advance Functional Cur...

12/27/2024CDE Issues the List of Reference Formulations for GQCE Studies (87th B...

12/27/2024Collaborative Governance Mechanism for Healthcare, Medical Insurance, ...

12/27/2024China's Commercial Health Insurance: Growth Trends and Challenges in C...

12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...

12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...

12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...

12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D

12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research

12/25/2024Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations

12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval

12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray

12/25/2024NMPA Announces Package Insert Revision of Human Tetanus Immunoglobulin...

12/24/2024Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...

Page:29/53 Total number of articles:1570: [First][<<] [27] [28] [29] [30] [31] [>>] [End]